351 related articles for article (PubMed ID: 4703827)
21. The effects of drugs on the behavioural and biochemical actions of intraventricular 6-hydroxydopamine.
Taylor KM; Laverty R
Eur J Pharmacol; 1972 Jan; 17(1):16-24. PubMed ID: 5016577
[No Abstract] [Full Text] [Related]
22. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
[No Abstract] [Full Text] [Related]
23. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
Peterson DW; Sparber SB
J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
[No Abstract] [Full Text] [Related]
24. Changes in rabbit core temperature accompanying alterations in brainstem monoamine concentrations.
Shellenberger MK; Elder JT
J Pharmacol Exp Ther; 1967 Nov; 158(2):219-26. PubMed ID: 6065145
[No Abstract] [Full Text] [Related]
25. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
Le Moal M; Stinus L; Simon H; Tassin JP; Thierry AM; Blanc G; Glowinski J; Cardo B
Adv Biochem Psychopharmacol; 1977; 16():237-45. PubMed ID: 883544
[No Abstract] [Full Text] [Related]
26. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
Vetulani J; Reichenberg K; Wiszniowska G
Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
[No Abstract] [Full Text] [Related]
27. A study of the central effects of 5,6-dihydroxytryptamine.
Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
[No Abstract] [Full Text] [Related]
28. Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats. I. Possible role of dopaminergic nervous system.
Fujimori K; Iwamoto T
Neuropharmacology; 1974 Apr; 13(4):245-54. PubMed ID: 4853135
[No Abstract] [Full Text] [Related]
29. [Adaptation to the behavioral effects of 6-hydroxydopamine].
Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
[No Abstract] [Full Text] [Related]
30. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
Lenard LG; Beer B
Pharmacol Biochem Behav; 1975; 3(5):887-93. PubMed ID: 1208631
[TBL] [Abstract][Full Text] [Related]
31. Physiological and behavioral effects of centrally-administered 6-hydroxydopamine in cats.
Howard JL; Breese GR
Pharmacol Biochem Behav; 1974; 2(5):651-61. PubMed ID: 4431828
[No Abstract] [Full Text] [Related]
32. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
Cooper BR; Grant LD; Breese GR
Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
[No Abstract] [Full Text] [Related]
33. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
34. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
Segal DS; McAllister C; Geyer MA
Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
[No Abstract] [Full Text] [Related]
35. Role of catecholamines in the central effects of amphetamine.
Pfeifer AK; György L; Fodor M
Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
[No Abstract] [Full Text] [Related]
36. 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
Johnson GA; Kim EG; Boukma SJ
J Pharmacol Exp Ther; 1972 Mar; 180(3):539-46. PubMed ID: 5012781
[No Abstract] [Full Text] [Related]
37. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
Buterbaugh GG; Spratt JL
J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
[No Abstract] [Full Text] [Related]
38. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
Andén NE
Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
[No Abstract] [Full Text] [Related]
39. Effects of chronic administration of food colorings on activity levels and cognitive performance in developing rat pups treated with 6-hydroxydopamine.
Shaywitz BA; Goldenring JR; Wool RS
Neurobehav Toxicol; 1979; 1(1):41-7. PubMed ID: 551301
[No Abstract] [Full Text] [Related]
40. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
Seiden LS; Peterson DD
J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
